Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
outbreak of herpes; This non-serious case was reported by a physician via sales rep and described the occurrence of herpes virus infection in a female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included herpes virus infection. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced herpes virus infection (Verbatim: outbreak of herpes). The outcome of the herpes virus infection was not reported. The reporter considered the herpes virus infection to be related to Shingrix. The company considered the herpes virus infection to be related to Shingrix. Additional Information: GSK Receipt Date: 26-MAR-2025 Patient reported that vaccine caused outbreak of herpes.
Medical History/Concurrent Conditions: Herpes virus infection